Opinions
VOLUME: 36 | ISSUE: 2S | Jun 24, 2020 | PAGE: (31 - 32) | DOI: 10.24911/BioMedica//BioMedica/5-378
Ivermectin: An Anti-Parasitic Drug that has Potential for Repurposing for COVID-19
Authors: Maryam Rashid , Mariyam Iftikhar Piracha
Article Info
Authors
Maryam Rashid
Department of Pharmacology & Therapeutics, Akhtar Saeed Medical & Dental College, Lahore– Pakistan.
Mariyam Iftikhar Piracha
Department of Pharmacology & Therapeutics, Akhtar Saeed Medical & Dental College, Lahore – Pakistan.
Publication History
Received: May 10, 2020
Revised: May 18, 2020
Accepted: June 17, 2020
Published: June 24, 2020
Abstract
After global health catastrophe due to Coronavirus disease-2019 (COVID-19), a deep impact on the way we perceive our world and our everyday lives has been imprinted. Till now, no specific antiviral drug has been proven effective for curing patients. Ivermectin, the broad-spectrum macrocyclic lactone has proven to exert antiviral activity against human immunodeficiency virus (HIV), dengue virus and now capability to reduce viral RNA up to 5,000-fold after 48 h of infection with SARS-CoV-2.
Keywords: COVID-19, SARS-CoV-2, Ivermectin, antiviral drugs.
